ID SPSB2_MOUSE Reviewed; 264 AA. AC O88838; Q8CBA5; Q91Z15; DT 30-MAY-2006, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1998, sequence version 1. DT 10-AUG-2010, entry version 76. DE RecName: Full=SPRY domain-containing SOCS box protein 2; DE Short=SSB-2; DE AltName: Full=Gene-rich cluster protein C9; GN Name=Spsb2; Synonyms=Grcc9, Ssb2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX MEDLINE=98112780; PubMed=9445485; RA Ansari-Lari M.A., Oeltjen J.C., Schwartz S., Zhang Z., Muzny D.M., RA Lu J., Gorrell J.H., Chinault A.C., Belmont J.W., Miller W., RA Gibbs R.A.; RT "Comparative sequence analysis of a gene-rich cluster at human RT chromosome 12p13 and its syntenic region in mouse chromosome 6."; RL Genome Res. 8:29-40(1998). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RA Friedel E.J., Nicholson S.E., Nicola N.A., Kile B.T., Hilton D.J.; RT "SOCS box proteins."; RL Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC STRAIN=C57BL/6J; TISSUE=Bone; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., RA Davis M.J., Wilming L.G., Aidinis V., Allen J.E., RA Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., RA Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., RA Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., RA Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., RA di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., RA Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., RA Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., RA Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., RA Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., RA Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., RA Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., RA Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., RA Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., RA Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., RA Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., RA Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., RA Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., RA Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., RA Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., RA Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., RA Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., RA Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., RA Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., RA Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., RA Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., RA Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., RA Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., RA Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., RA Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., RA Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC STRAIN=FVB/N; TISSUE=Mammary gland, and Mammary tumor; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP STRUCTURE BY NMR OF 12-224, INTERACTION WITH PAWR AND MET, AND RP MUTAGENESIS OF TYR-120; 123-LEU--GLY-125; 141-TYR--GLN-143; RP 151-GLN-TYR-152; 188-GLY-PRO-189 AND VAL-206. RX PubMed=16369487; DOI=10.1038/nsmb1034; RA Masters S.L., Yao S., Willson T.A., Zhang J.-G., Palmer K.R., RA Smith B.J., Babon J.J., Nicola N.A., Norton R.S., Nicholson S.E.; RT "The SPRY domain of SSB-2 adopts a novel fold that presents conserved RT Par-4-binding residues."; RL Nat. Struct. Mol. Biol. 13:77-84(2006). CC -!- FUNCTION: Probable substrate recognition component of a SCF-like CC ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein CC ligase complex which mediates the ubiquitination and subsequent CC proteasomal degradation of target proteins (By similarity). CC -!- PATHWAY: Protein modification; protein ubiquitination. CC -!- SUBUNIT: Interacts with PARW and MET. Component of the probable CC ECS(SPSB2) E3 ubiquitin-protein ligase complex which contains CC CUL5, RNF7/RBX2, Elongin BC complex and SPSB2. Interacts with CC CUL5, RNF7, TCEB1 and TCEB2 (By similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm (Probable). CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=O88838-1; Sequence=Displayed; CC Name=2; CC IsoId=O88838-2; Sequence=VSP_018613; CC Note=No experimental confirmation available; CC -!- DOMAIN: The SOCS box domain mediates the interaction with the CC Elongin BC complex, an adapter module in different E3 ubiquitin CC ligase complexes (By similarity). CC -!- SIMILARITY: Belongs to the SPSB family. CC -!- SIMILARITY: Contains 1 B30.2/SPRY domain. CC -!- SIMILARITY: Contains 1 SOCS box domain. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AC002397; AAC36017.1; -; Genomic_DNA. DR EMBL; AF403037; AAL57356.1; -; mRNA. DR EMBL; AK036451; BAC29435.1; -; mRNA. DR EMBL; AK148177; BAE28397.1; -; mRNA. DR EMBL; BC002005; AAH02005.1; -; mRNA. DR EMBL; BC010305; AAH10305.1; -; mRNA. DR IPI; IPI00135183; -. DR IPI; IPI00460358; -. DR RefSeq; NP_038567.1; -. DR UniGene; Mm.261906; -. DR PDB; 2AFJ; NMR; -; A=12-224. DR PDB; 3EK9; X-ray; 2.60 A; A=12-224. DR PDBsum; 2AFJ; -. DR PDBsum; 3EK9; -. DR ProteinModelPortal; O88838; -. DR DIP; DIP-29001N; -. DR STRING; O88838; -. DR PRIDE; O88838; -. DR Ensembl; ENSMUST00000047760; ENSMUSP00000041585; ENSMUSG00000038451; Mus musculus. DR Ensembl; ENSMUST00000052727; ENSMUSP00000060124; ENSMUSG00000038451; Mus musculus. DR Ensembl; ENSMUST00000112474; ENSMUSP00000108093; ENSMUSG00000038451; Mus musculus. DR GeneID; 14794; -. DR KEGG; mmu:14794; -. DR UCSC; uc009drw.1; mouse. DR CTD; 14794; -. DR MGI; MGI:1315199; Spsb2. DR eggNOG; maNOG13004; -. DR HOGENOM; HBG315310; -. DR HOVERGEN; HBG055793; -. DR InParanoid; O88838; -. DR OMA; PAVSAVW; -. DR OrthoDB; EOG941SXT; -. DR PhylomeDB; O88838; -. DR NextBio; 286943; -. DR ArrayExpress; O88838; -. DR Bgee; O88838; -. DR Genevestigator; O88838; -. DR GermOnline; ENSMUSG00000038451; Mus musculus. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR InterPro; IPR001870; B302. DR InterPro; IPR001496; SOCS_C. DR InterPro; IPR018355; SPla/RYanodine_receptor_sg. DR InterPro; IPR003877; SPRY_rcpt. DR Pfam; PF07525; SOCS_box; 1. DR Pfam; PF00622; SPRY; 1. DR SMART; SM00253; SOCS; 1. DR SMART; SM00449; SPRY; 1. DR PROSITE; PS50188; B302_SPRY; 1. DR PROSITE; PS50225; SOCS; 1. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Cytoplasm; KW Ubl conjugation pathway. FT CHAIN 1 264 SPRY domain-containing SOCS box protein FT 2. FT /FTId=PRO_0000238475. FT DOMAIN 26 221 B30.2/SPRY. FT DOMAIN 222 264 SOCS box. FT VAR_SEQ 222 264 VEEPQSLLHLSRLCVRHALGDTRLGQISTLPLPPAMKRYLL FT YK -> GEIRTRCGEITTLGNGLGWKLMVGAQEVGFLSLWP FT VT (in isoform 2). FT /FTId=VSP_018613. FT MUTAGEN 120 120 Y->A: Loss of interaction with PARW. No FT effect on interaction with MET. FT MUTAGEN 123 125 LLG->AAA: Loss of interaction with MET FT and PARW. FT MUTAGEN 141 143 YHQ->AAA: Strongly reduced interaction FT with MET and PARW. FT MUTAGEN 151 152 QY->AA: Loss of interaction with MET and FT PARW. FT MUTAGEN 188 189 GP->AA: Strongly reduced interaction with FT MET. Loss of interaction with PARW. FT MUTAGEN 206 206 V->A: Loss of interaction with PARW. No FT effect on interaction with MET. FT STRAND 27 29 FT HELIX 30 33 FT HELIX 42 46 FT STRAND 51 53 FT STRAND 56 60 FT TURN 61 64 FT STRAND 65 67 FT TURN 72 74 FT STRAND 75 80 FT STRAND 87 94 FT STRAND 99 101 FT STRAND 105 112 FT STRAND 119 121 FT STRAND 129 134 FT HELIX 135 137 FT STRAND 142 145 FT STRAND 150 153 FT HELIX 157 160 FT STRAND 167 172 FT TURN 173 176 FT STRAND 177 182 FT HELIX 191 197 FT STRAND 200 205 FT STRAND 213 218 SQ SEQUENCE 264 AA; 28938 MW; E71985597D9B38CB CRC64; MGQTALARGS SSTPTSQALY SDFSPPEGLE ELLSAPPPDL VAQRHHGWNP KDCSENIDVK EGGLCFERRP VAQSTDGVRG KRGYSRGLHA WEISWPLEQR GTHAVVGVAT ALAPLQADHY AALLGSNSES WGWDIGRGKL YHQSKGLEAP QYPAGPQGEQ LVVPERLLVV LDMEEGTLGY SIGGTYLGPA FRGLKGRTLY PSVSAVWGQC QVRIRYMGER RVEEPQSLLH LSRLCVRHAL GDTRLGQIST LPLPPAMKRY LLYK //